The upcoming 2016 World Congress on Industrial Biotechnology is the preeminent conference for connecting venture capital with promising industrial biotech companies. “I’ve been coming since 2007,” said Michael Krel of Sofinnova Partners in a recent conversation, “and I’ve been quite happy with partnering at World Congress, and it is very efficient.” By “partnering”, Michael is talking about the BIO One-on-One Partnering system used to setup 30-minute, private, face-to-face meetings at the conference. The system has been enhanced for 2016 with industrial biotech fields and values, special profiles and functionality for investors, Outlook/Gmail integration, and much more. It is the only system with features specific to connecting VCs with industrial biotech companies.
Investors will find more than promising companies at World Congress. The opportunity to connect with other industrial biotech VCs as well as meet with large companies to collaborate on exits for portfolio companies makes the event a must-go.
Companies are advised to cater their pitch appropriately during VC partnering meetings. It’s important to remember that investors are interested in companies, not projects. As such, a business-focused partnering meeting with an investor is preferable to pitching the science as heavily as is typical in a company presentation. Companies that understand the pros and cons of having VC funding will fare well in investor meetings, as that ground will not need to be covered and will show that the company has done their homework.
“You can meet everyone from North America in one place at World Congress – it’s a great travel and time savings.” concluded Michael. He’s right. The 2015 World Congress hosted 1,400 partnering meetings over its three-day span. Companies participating in partnering came from across the industry, including the biofuels, renewable chemicals, biobased materials, research & development, algae technology development and many other sectors. Besides investors like Sofinnova, Mitsui Global Investment, CAPRICORN Venture Partners, BioEngine Venture Capital and Cycle Capital Management, companies like DSM, Dow Chemical, DuPont, BASF, Cargill and Verdezyne provide a rich business development and in-licensing ecosystem to complement. And investors and companies alike are easily accessible for meetings through BIO’s One-on-One Partnering system.
To learn more about One-on-One Partnering at the 2016 World Congress visit: go.bio.org/WorldCongress2016. Also join us in March for a special Partnering Webinar that will provide an overview of BIO’s new system and educate attendees on how to get the most out of their 30-minute partnering meetings.